Post COVID-19, the need for medication to be administered in a home setting will be greater than ever. Without the provision of a connected solution however, there is an inherent risk that lifesaving medication will not be delivered with the necessary compliance, and as a result patient adherence will suffer. We must find a safe, secure and data driven way forward.
The changing landscape
During this webinar we look at the impact of COVID-19 on clinical trials, patient recruitment, and monitoring; and the changing patient/ physician relationship. We then focus on the power of digital health and the data that can be generated to support clinical trials.
Treatment at home
We then look at the mainstream adoption of digital health in the home/everyday environment, discussing the benefits of training, onboarding, and diagnostics.
Scaling up for broader deployment
When moving from the clinical trial phase to mass adoption, there is a need to ensure solutions can scale. We review the pitfalls, challenges, and benefits of digital health and how this can be delivered in the most sustainable way possible. COVID-19 has irreversibly changed the home administration landscape. This webinar demonstrates how digital health solutions are an imperative to ensure safe, secure, efficient, and effective, patient outcomes.